RDUS Radius Pharmaceuticals: Rasio rega marang prakiraan pendapatan
Endocrinologists' confidence in the bone metabolism expertise of Radius Recycling, Inc. (RDUS) supports positive momentum, with the estimated forward P/S currently around 0.30. Stable FCF and patent protection ensure high margins, while experienced management effectively optimizes debt load and costs. This chart trend confirms the market valuation of the business's fundamental stability.
Ringkesan rincian data analitis Radius Pharmaceuticals (RDUS)
- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas Radius Recycling, Inc.|RDUS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Radius Recycling, Inc.|RDUS - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Radius Pharmaceuticals|RDUS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Radius Recycling|Rasio cepet radiuspharm.com
- rincian asil keuangan lan kelipatan valuasi:
RDUS - Asil keuangan resik|Bathi mangsa ngarep Radius Recycling, Inc.|RDUS - Pangali P/E|Rega marang bathi mangsa ngarep Radius Health|RDUS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Radius Pharmaceuticals|RDUS - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Radius Recycling|RDUS - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan radiuspharm.com|RDUS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Radius Recycling, Inc.
- indikator volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:Radius Recycling RDUS
The forward P/S reflects the market value of the business relative to projected revenue, allowing for an assessment of the discount rate applied to future cash flows while filtering out random market noise. For Radius Recycling, Inc. (RDUS), the forward P/S demonstrates how logistics optimization and energy-efficient scrap shredding impact capitalization during periods of cyclical volatility, determining the long-term sustainability of invested capital.
Pesaing Radius Recycling, Inc.
Rasio rega marang prakiraan pendapatan Ascendis Pharma ASND|Madrigal Pharmaceuticals Inc (MDGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CORT - Rasio rega marang prakiraan pendapatan|RYTM: Rasio rega marang prakiraan pendapatan|AKRO: Multiplikator Forward P/S|MTSR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan MoonLake|Crinetics Pharmaceuticals, Inc. (CRNX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan NewAmsterdam Pharma N.V. (NAMS)|Multiplikator forward rega marang pendapatan Soleno Therapeutics Corp SLNO|Rasio rega marang prakiraan pendapatan Amicus Therapeutics FOLD|Rega forward marang dodolan ETNB|Agios Pharmaceuticals, Inc. - Multiplikator Forward P/S|GPCR - Multiplikator Forward P/S|MDXG: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan RZLT|LXRX (Lexicon Pharmaceuticals) - Multiplikator Forward P/S|mbxbio.com (MBX) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan ALT (Altimmune)|Multiplikator Forward P/S Aardvark Therapeutics Inc. (AARD)|Rasio rega marang prakiraan pendapatan Sagimet SGMT|Rasio kapitalisasi marang dodolan sing dikarepake BioAge Labs, Inc (BIOA)|BMEA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QNCX (Quince Therapeutics)|Fractyl Health (GUTS) - Rasio rega marang prakiraan pendapatan|vTv Therapeutics - Rega forward marang dodolan|ATPC (Agape ATP Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Pluri Inc PLUR|Multiplikator Forward P/S SYBX|Multiplikator forward rega marang pendapatan lipocine.com LPCN|Matinas BioPharma Holdings - Multiplikator forward rega marang pendapatan|Spruce Biosciences Inc. (SPRB) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Galecto Corp - Multiplikator Forward P/S|Carmell Therapeutics (CTCX) - Multiplikator forward rega marang pendapatan|Lumos Pharma, Inc. (LUMO) - Rasio rega marang prakiraan pendapatan|ONVO (organovo.com) - Rasio rega marang prakiraan pendapatan
